Pulmonary Hypertension Trial, Recruiting (NCT06105242)

Pulmonary Hypertension Trial, Recruiting NCT06105242 Sponsor: Intermountain Health Care, Inc. Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06105242 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who have been diagnosed with a specific type of pulmonary hypertension called CTEPH (chronic thromboembolic pulmonary hypertension), following current medical guidelines
People who had a heart ultrasound (echocardiogram) taken within 3 months of their diagnosis, with clear enough image quality for a specific heart function measurement called RVGLS analysis
People who had a procedure called a right heart catheterization (a test that measures pressures inside the heart) at the time of their diagnosis
For one part of the study (Aim 2): people who have undergone a specific surgery called pulmonary thromboendarterectomy (PTE) and had a follow-up heart ultrasound performed between 3 and 9 months after surgery, with clear enough images for RVGLS analysis

Who may not be able to join:

People whose pulmonary hypertension diagnosis is unclear or mixed, as determined by a specialist at the Intermountain Pulmonary Hypertension Centre
People under 18 years of age
People who were diagnosed with CTEPH during pregnancy
People who did not have both a heart ultrasound and a right heart catheterization at the time of their diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06105242

Sponsor: Intermountain Health Care, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

More information: https://clinicaltrials.gov/study/NCT06105242

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who have been diagnosed with a specific type of pulmonary hypertension called CTEPH (chronic thromboembolic pulmonary hypertension), following current medical guidelines
People who had a heart ultrasound (echocardiogram) taken within 3 months of their diagnosis, with clear enough image quality for a specific heart function measurement called RVGLS analysis
People who had a procedure called a right heart catheterization (a test that measures pressures inside the heart) at the time of their diagnosis
For one part of the study (Aim 2): people who have undergone a specific surgery called pulmonary thromboendarterectomy (PTE) and had a follow-up heart ultrasound performed between 3 and 9 months after surgery, with clear enough images for RVGLS analysis

Who may not be able to join:

People whose pulmonary hypertension diagnosis is unclear or mixed, as determined by a specialist at the Intermountain Pulmonary Hypertension Centre
People under 18 years of age
People who were diagnosed with CTEPH during pregnancy
People who did not have both a heart ultrasound and a right heart catheterization at the time of their diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Intermountain Health Care, Inc.

Registry

ClinicalTrials.gov

Start date

30 May 2022

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biosphere; Biopshere; Biosphere

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov